GOG 172:IV 紫杉醇-猫眼课题宝

GOG 172:IV 紫杉醇

批准号：

6265786

负责人：

WILLIAM R ROBINSON

金额：

$1.12万

依托单位：

TULANE UNIVERSITY OF LOUISIANA

依托单位国家：

美国

项目类别：

财政年份：

1999

资助国家：

美国

项目状态：

已结题

起止时间：

1999-07-19 至 1999-11-30

来源：

https://reporter.nih.gov/project-details/6265786

关键词：

abdomen antineoplastics carcinoma cis platinum compound clinical research drug administration routes human subject human therapy evaluation neoplasm /cancer chemotherapy ovary neoplasms paclitaxel quality of life

项目摘要

项目成果

WILLIAM R ROBINSON的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The standard treatment for optimally debulked Stage III ovarian or primary peritoneal carcinoma is chemotherapy with intravenous Cisplatin and Paclitaxel. The purpose of this study is to determine the effectiveness of administration of chemotherapy into the abdominal cavity in addition to intravenous chemotherapy compared to the current standard intravenous chemotherapy. Because ovarian cancer spreads in the abdominal cavity, giving chemotherapy by infusion into the abdominal cavity may result in a greater dose of the drugs reaching tumor cells. This study will evaluate the patient's response, and survival/disease free interval when treated with standard intravenous Cisplatin and Paclitaxel compared to intravenous Paclitaxel and intraperitoneal Cisplatin and Paclitaxel. The study will also evaluate the impact of treatment on the patient's quality of life.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文